Skip to main content

Caterina Fernàndez Garberi

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Caterina Fernàndez Garberi

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Manuel Gomez Duque

Manuel Gomez Duque

Predoctoral researcher
Growth and Development
Read more
Sara Lucas del Pozo

Sara Lucas del Pozo

Predoctoral researcher
Neurodegenerative Diseases
Read more
Eva Balada Prades

Eva Balada Prades

Senior researcher
Microbiology
Read more
Olga Palà Tristany

Olga Palà Tristany

Predoctoral researcher
Biomedical Research in Gynaecology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.